Scholars Central

CommentaryPublished 30 Dec 2021

A Brief Synoptic Note on Chemotherapy for Cancer Patients

Authors: Luca Malorni

European Journal of Clinical Oncology

Volume 3 · Issue 4 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Chemotherapy has come back to imply non-specific usage of intracellular poisons to inhibit cell division or induce Deoxyribonucleic Acid (DNA) harms, specifically inhibition of deoxyribonucleic acid repair will augment therapy. The implication of the word therapy excludes additional selective agents that block extracellular signals (signal transduction). The result of therapies with specific molecular or genetic targets, that inhibit growth-promoting signals from classic endocrine hormones primarily estrogens for carcinoma and androgens for prostate cancer area unit currently known as secretion therapies. Different inhibitions of growth-signals like those related to receptor Aminopolycarboxylic Acid (APCA) kinases area unit are targeted medical therapy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalEuropean Journal of Clinical Oncology
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Luca Malorni”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels